Key result
Non-BPharm pharmacists show ~6-point higher warfarin awareness scores than BPharm holders.
Why the study?
Warfarin requires careful monitoring due to its narrow therapeutic index and numerous interactions, and pharmacists play an important role in preventing warfarin-associated complications. This study was conducted to assess the warfarin-related knowledge and awareness of community pharmacists in Jeddah and Taif, Saudi Arabia.
Cross-Sectional (n=380)
Yes
Community pharmacists in Jeddah and Taif demonstrated moderate overall awareness of warfarin therapy (mean score 66.40%), though notable knowledge gaps in safety and drug interactions highlight the need for targeted continuing education.
Moderate pharmacist warfarin awareness may warrant targeted education; leaves open outcome impact in observational data alone.
Background/Objectives: Although warfarin remains an important oral anticoagulant for selected indications, careful monitoring is required due to its narrow therapeutic index and numerous interactions. As an integral part of anticoagulant monitoring systems globally, pharmacists play an important role in preventing warfarin-associated complications. The current study assessed the warfarin-related knowledge and awareness of community pharmacists in Jeddah and Taif, Saudi Arabia. Methods: This cross-sectional survey used convenience sampling to recruit 380 community pharmacists in Jeddah and Taif between October of 2024 and March of 2025. The questionnaire included 19 knowledge items covering warfarin’s safety (eight items), drug interactions (six items), and knowledge related to patient counseling (five items). Percentage awareness scores (PASs) were calculated for each domain, as well as the overall PAS. A predefined PAS threshold of ≥60% was used for descriptive categorization only. Unadjusted comparisons used independent-samples t-tests, with Mann–Whitney U tests performed as sensitivity analyses. Multivariable linear regression analysis with robust standard errors was conducted to examine adjusted associations with the overall PAS. Results: Mean PAS values were 65.39% for safety, 61.18% for drug interactions, 74.26% for patient counseling knowledge, and 66.40% overall. A total of 258 participants (67.9%) exceeded the predefined PAS threshold of ≥60%. Gender, age, experience, board certification, and anticoagulation training were not significantly associated with PAS values. In the multivariable analysis, the combined non-BPharm group had higher overall PAS than BPharm holders (adjusted difference: 5.99 percentage points; 95% CI: 2.54–9.44; p < 0.001). Non-Saudi nationality was also associated with higher overall PAS (adjusted difference: 4.27 percentage points; 95% CI: 0.05–8.48; p = 0.047). Conclusions: Most participants met the predefined descriptive PAS threshold, although it should be noted that this does not establish clinically adequate knowledge. Nevertheless, gaps were identified in safety, interactions, and counseling. Targeted continuing professional education is warranted, and future studies should examine counseling practices and patient outcomes.
No takes yet. Share an insight, caveat, or question.
Basilim et al. (2026) conducted a cross-sectional in Warfarin therapy knowledge and awareness (n=380). Non-BPharm degree vs. BPharm degree holders was evaluated on Overall percentage awareness score (PAS) regarding warfarin therapy (MD 5.99, 95% CI 2.54-9.44, p=<0.001). Non-BPharm community pharmacists had a higher warfarin awareness score than BPharm holders (adjusted difference 5.99%; 95% CI 2.54-9.44; p<0.001), with an overall mean score of 66.40%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: